Hypertension in pregnancy: Diagnosis and treatment

Mayo Clinic Proceedings

Volumn 75, Issue 10, 2000, Pages 1071-1076

  Garovic, Vesna D ^a  

^a Division of Nephrology and Hypertension   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDRALAZINE; METHYLDOPA; NIFEDIPINE; NITROPRUSSIDE SODIUM; ANGIOTENSIN RECEPTOR ANTAGONIST; DIAZOXIDE; LABETALOL; PLACEBO; VASODILATOR AGENT;

BLOOD PRESSURE; BRADYCARDIA; CEREBROVASCULAR DISEASE; DEATH; FETUS MORTALITY; FETUS RISK; GROWTH RETARDATION; HEART DISEASE; HELLP SYNDROME; HUMAN; HYPERTENSION; HYPOGLYCEMIA; HYPOXIA; KIDNEY DISEASE; MATERNAL HYPERTENSION; MATERNAL MORBIDITY; MATERNAL MORTALITY; PLACENTA CIRCULATION; PREECLAMPSIA; PREGNANCY; PREMATURE LABOR; PRENATAL DRUG EXPOSURE; REVIEW; BED REST; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG SAFETY; HYPOTENSION; LOW DRUG DOSE; MORBIDITY; MORTALITY; SODIUM RESTRICTION; UNITED STATES;

EID: 0033795475     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/75.10.1071     Document Type: Review

References (26)

1. McLaughlin MK, Roberts JM. Hemodynamic changes. In: Lindheimer MD, Roberts JM, Cunningham FG, eds. Chesley's Hypertensive Disorders in Pregnancy. 2nd ed. Stamford, Conn: Appleton & Lange; 1999:69-102.
2. National High Blood Pressure Education Program Working Group Report on High Blood Pressure in Pregnancy. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000; 183(l,suppl):Sl-S22.
3. Van Dongen PW, Eskes TK, Martin CB, Van 't Hof MA. Postural blood pressure differences in pregnancy: a prospective study of blood pressure differences between supine and left lateral position as measured by ultrasound. Am J Obstet Gynecol. 1980; 138:1 5.
4. Lindheimer MD, Roberts JM, Cunningham FG, Chesley L. Introduction, history, controversies, and definitions. In: Lindheimer MD, Roberts JM, Cunningham FG, eds. Chesley's Hypertensive Disorders in Pregnancy. 2nd ed. Stamford, Conn: Appleton & Lange; 1999:3-41.
5. August P. Preeclampsia: new thoughts on an ancient problem. J Clin Hypertens. 2000;2:115-123.
6. Visser W, Wallenburg HC. Central hemodynamic observations in untreated preeclamptic patients. Hypertension. 1991;17:10721077.
7. Sibai BM, Mercer BM, Schiff E, Friedman SA. Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial. Am J Obstet Gynecol. 1994; 171:818-822.
8. Cunningham FG, Lindheimer MD. Hypertension in pregnancy. N EnglJMed. 1992;326:927-932.
9. Sibai BM, Anderson GD. Pregnancy outcome of intensive therapy in severe hypertension in first trimester. Obstet Gynecol. 1986:67: 517-522.
10. Sibai BM, Abdella TN, Andersen GD. Pregnancy outcome in 211 patients with mild chronic hypertension. Obslet Gynecol. 1983;61: 571-576.
11. Sibai BM. Treatment of hypertension in pregnant women. N Engt J Med. 1996;335:257-265.
12. Weitz C, Khouzami V, Maxwell K, Johnson JW. Treatment of hypertension in pregnancy with methyldopa: a randomized double blind study. Int J Gynaecol Obstet. 1987;25:35-40.
13. Chesley LC, Sibai BM. Clinical significance of elevated mean arterial pressure in the second trimester. Am J Obstet Gynecol. 1988:159:275-279.
14. Cockburn J, Moar VA, Ounsted M, Redman CW. Final report of study on hypertension during pregnancy: the effects of specific treatment on the growth and development of the children. Lancet. 1982;l:647-649.
15. Umans JG, Lindheimer MD. Antihypertensive treatment. In: Lindheimer MD, Roberts JM, Cunningham FG, eds. Chesley's Hypertensive Disorders in Pregnancy. 2nd ed. Stamford, Conn: Appleton & Lange; 1999:581-604.
16. Butters L, Kennedy S, Rubin PC. Atenolol in essential hypertension during pregnancy. BMJ. 1990:301:587-589.
17. Ismail AA, Medhat I, Tawfic TA, Kholeif A. Evaluation of calcium-antagonist (Nifedipine) in the treatment of pre-eclampsia. Int J Gynaecol Obster. 1993:40:39-43.
18. Pryde PG, Sedman AB, Nugent CE, Barr M Jr. Angiotensin-converting enzyme inhibitor fetopathy. J Am Soc Nephrol. 1993;3: 1575-1582.
19. Papiernik E, Kaminski M. Multifactorial study of the risk of prematurity at 32 weeks of gestation, 1: a study of the frequency of 30 predictive characteristics. J Perinat Med. 1974;2:30-36.
20. Steegers EA, Eskes TK, Jongsma HW, Hein PR. Dietary sodium restriction during pregnancy: a historical review. Eur J Obstet Gynecol Reprod Biol. 1991 ;40:83-90.
21. Spatling L, Spatling G. Magnesium supplementation in pregnancy: a double-blind study. Br J Obstet Gynaecol. 1988;95:120-125.
22. Salvig JD, Olsen SF, Secher NJ. Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled trial. Br J Obstet Gynaecol. 1996; 103:529-533.
23. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet. 1994;343:619-629.
24. Caritis S, Sibai B, Hauth J. et al. Low-dose aspirin to prevent preeclampsia in women at high risk. N Engl J Med. 1998;338:701-705.
25. Levine RJ, Hauth JC, Curet LB, et al. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Trial of calcium to prevent preeclampsia. N Engl J Med. 1997:337:69-76.
26. Chappell LC, Seed PT, Briley AL, et al. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial. Lancet. 1999;354:8IO-816.